This increase in IL-22 levels has been shown to mitigate hepatic steatosis.46 These findings suggest that hepatic ILC3s play a protective role against MAFLD by secreting the hepatoprotective cytokine, IL-22. The gene discussed is IL22; the disease is fatty liver disease.